Sage Journals: Discover world-class research

Abstract

Keywords

“orthobiologics”cell therapy platelet-rich plasma reporting standards

Get full access to this article

View all access options for this article.

References

Jones

Chen

Evseenko

Vangsness

Jr.

Nomenclature inconsistency and selective outcome reporting hinder understanding of stem cell therapy for the knee. J Bone Joint Surg Am. 2019;101(2):186-195.

Murray

Geeslin

Goudie

Petrigliano

LaPrade

. Minimum information for studies evaluating biologics in orthopaedics (MIBO): platelet-rich plasma and mesenchymal stem cells. J Bone Joint Surg Am. 2017;99(10):809-819.

Wei

Lee

Chen

. Pharmacogenomics of adverse drug reactions: implementing personalized medicine. Hum Mol Genet. 2012;21(R1):R58-R65.

The Need for Minimum Reporting Standards for Studies of “Biologics” in Sports Medicine

Abstract

Keywords

Get full access to this article

References